NNPTE
MLYS icon

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Mineralys Therapeutics MLYS Stock Holding History

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-104,961
Closed -$2.84M – 50
2026
Q1 		$2.84M Sell
104,961
-554,115
-84% -$16.3M 0.24% 36
2025
Q4 		$23.9M Buy
+659,076
New +$26.4M 2.12% 18

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's MLYS Position: Q2 2026 in Review

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold out of Mineralys Therapeutics (MLYS) in Q2 2026, closing a stake of 104,961 shares — an estimated $2.84M sold.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in MLYS in Q4 2025 and held it in 2 quarters. The position peaked at $23.9M in Q4 2025. 95 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne reported no remaining Mineralys Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold 104,961 Mineralys Therapeutics shares in Q2 2026, an estimated $2.84M.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in Mineralys Therapeutics in Q4 2025 and held it in 2 quarters.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's Mineralys Therapeutics position peaked at $23.9M in Q4 2025.
  • 95 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's 13F filing for Q2 2026, filed 7 Aug 2026.